Association between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: Results from prospective nationwide KOBIO Registry

There has been some debate between biologic disease modifying anti-rheumatic drugs (bDMARDs) treatment and hypertension (HTN) in rheumatoid arthritis (RA). The aim of this study was to determine the effect of bDMARDs on the development of HTN in patients with RA. A total of 996 patients eligible for...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seong-Kyu, Kwak, Sang Gyu, Choe, Jung-Yoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478791/
https://www.ncbi.nlm.nih.gov/pubmed/32118795
http://dx.doi.org/10.1097/MD.0000000000019415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478791/
https://www.ncbi.nlm.nih.gov/pubmed/32118795
http://dx.doi.org/10.1097/MD.0000000000019415

Ejemplares similares